Literature DB >> 6801667

Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.

W A Hankins, J M Gwaltney, J O Hendley, J D Farquhar, J S Samuelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6801667     DOI： 10.3181/00379727-169-41306

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  11 in total

1.  Isolation of Neisseria meningitidis mutants deficient in class 1 (porA) and class 3 (porB) outer membrane proteins.

Authors:  J Tommassen; P Vermeij; M Struyvé; R Benz; J T Poolman
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

2.  Status of a group B Neisseria meningitidis vaccine.

Authors:  C E Frasch
Journal:  Eur J Clin Microbiol       Date:  1985-12       Impact factor: 3.267

3.  Molecular cloning and expression of Neisseria meningitidis class 1 outer membrane protein in Escherichia coli K-12.

Authors:  A K Barlow; J E Heckels; I N Clarke
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

4.  Preparation and immunochemical characterization of meningococcal group C polysaccharide-tetanus toxoid conjugates as a new generation of vaccines.

Authors:  E C Beuvery; F Miedema; R van Delft; J Haverkamp
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

Review 5.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

6.  Development of a Neisseria meningitidis group B serotype 2b protein vaccine and evaluation in a mouse model.

Authors:  L Y Wang; C E Frasch
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

7.  Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine.

Authors:  A E Platonov; V B Beloborodov; L I Pavlova; I V Vershinina; H Käyhty
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

8.  Experimental meningococcal infection in mice: a model for mucosal invasion.

Authors:  I E Salit; L Tomalty
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

9.  Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease.

Authors:  D M Granoff; S K Kelsey; H A Bijlmer; L Van Alphen; J Dankert; R E Mandrell; F H Azmi; R J Scholten
Journal:  Clin Diagn Lab Immunol       Date:  1995-09

10.  Adverse events temporally associated with meningococcal vaccines.

Authors:  A Yergeau; L Alain; R Pless; Y Robert
Journal:  CMAJ       Date:  1996-02-15       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.